Suggestions
Camilla Razzo
Professional Background
Camilla Razzo is a highly accomplished Senior Product Manager working within the prestigious pharmaceutical company Roche. With a robust background in oncology and immunotherapy, Camilla has made significant strides in the healthcare industry, holding key positions that emphasize her leadership and strategic skills. Presently, she oversees the Avastin CRCM and Pan Tumor and Atezolizumab Pan Tumor and Muc portfolio at Roche, contributing to the innovative landscape of cancer treatment solutions.
Prior to her current role, Camilla has held several pivotal positions at Roche, such as Franchise Squad Lead for Oncology. In this capacity, she demonstrated exceptional leadership skills and a deep understanding of oncology products, enhancing the strategic direction of cancer therapies within the organization. Her expertise extends to managing the intricate details of product policies, market access, and product strategy that are crucial for driving market penetration and patient access to groundbreaking treatment options.
Camilla's journey at Roche commenced as a Product Manager, where she was instrumental in product development and marketing strategies for the Rheumatology franchise as well as cancer immunotherapy. Her experiences also cover various aspects of the product lifecycle, from ideation to market introduction, showcasing her capability to bridge the gap between scientific innovation and market needs.
Before her extensive career at Roche, Camilla garnered valuable insights into branding and marketing as a Marketing Manager at Diageo and U.D.V Diageo Portugal. Her work in these roles involved steering marketing strategies for prominent brands such as J&B, which laid the groundwork for her eventual transition into the pharmaceutical sector.
Education and Achievements
Camilla Razzo's academic journey began at Newcastle University, where she pursued a dual degree in Economics and Political Science. This strong educational foundation equipped her with analytical skills and a firm grasp of the socio-economic factors that influence market dynamics and healthcare policies. Understanding the intersection of economics and politics has proven beneficial in her roles within the product management sphere of the healthcare industry, empowering her to make informed decisions that positively impact patient outcomes and market strategies.
Camilla's achievements are not limited to her professional roles. Through her strategic vision and commitment to excellence, she has played a critical role in bringing innovative cancer therapies to market, enhancing the treatment landscape for oncological care. Her leadership contributions have significantly influenced the direction and success of various product lines, affirming her reputation as a thought leader within the industry.
Camilla possesses a unique blend of analytical prowess, market insight, and leadership skills that have enabled her to thrive in one of the most challenging yet rewarding sectors of healthcare. With her steadfast commitment to improving patient care and her continued contributions to groundbreaking research initiatives, Camilla Razzo stands out as a remarkable professional dedicated to advancing the field of oncology.
Achievements
-
Senior Product Manager at Roche: Currently manages a portfolio including Avastin CRCM and Atezolizumab Pan Tumor and Muc, contributing to innovative cancer treatment solutions.
-
Franchise Squad Lead - Oncology at Roche: Provided strategic leadership over oncology products, improving treatment accessibility and outcomes.
-
Group Product Manager: Oversaw cancer immunotherapy initiatives and directed product strategy for Rheumatology, Skin, and IPF.
-
Marketing Manager at Diageo: Developed and implemented successful marketing strategies for world-renowned brands, enhancing brand presence and market share.
Conclusion
In summary, Camilla Razzo represents a formidable presence in the pharmaceutical industry, particularly within the oncology arena. Her educational background in Economics and Political Science from Newcastle University helps her navigate complex healthcare landscapes effectively. With vast experience at Roche and exceptional achievements across her career, she is poised to continue making impactful contributions to the future of cancer treatment and immunotherapy.
